MedPath

Herbal cream of borage, evening primrose, calendula, and leek versus topical mometasone 0.01% for atopic dermatitis

Phase 3
Recruiting
Conditions
Atopic dermatitis.
Atopic dermatitis
Registration Number
IRCT20211216053428N1
Lead Sponsor
Vice chancellery of Research and Technology, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
62
Inclusion Criteria

Age >7 years
SCORAD score <50

Exclusion Criteria

Accompanying physical illness
Any physical illness preventing drug administration
Treatment in the past 6 months
Drug use or alcohol consumption in the past 6 months
Pregnancy or lactation
Lack of following up by the patient
Severe drug hypersensitivity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in SCORing Atopic Dermatitis (SCORAD). Timepoint: Weeks 0, 4, 8, and 12. Method of measurement: SCORing Atopic Dermatitis (SCORAD).
Secondary Outcome Measures
NameTimeMethod
Patient satisfaction with treatment. Timepoint: Weeks 4, 8, and 16. Method of measurement: 10-item visual analogue scale (VAS).
© Copyright 2025. All Rights Reserved by MedPath